← Back to Search

Local Anesthetic

Throat Numbing for Gagging

N/A

Waitlist Available

Research Sponsored by Royal Victoria Hospital, Canada

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 40 minutes

Awards & highlights

Study Summary

This trial will test whether numbing the back of the throat with lidocaine will reduce gagging during a medical procedure to put a tube down the throat.

Who is the study for?

This trial is for morbidly obese patients who are scheduled for bariatric surgery and require an awake intubation. Participants must be able to communicate in English or French, have no allergies to study drugs, and have an American Society of Anesthesiologists score less than 4.Check my eligibility

What is being tested?

The study is testing whether applying a gauze soaked with 2% lidocaine to the throat area can reduce gagging during awake tracheal intubation using a videolaryngoscope in morbidly obese individuals.See study design

What are the potential side effects?

Potential side effects may include reactions at the application site such as numbness, tingling sensation, or mild discomfort due to lidocaine. There's also a low risk of allergic reaction if sensitivity to lidocaine exists.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 40 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~40 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 40 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Gagging

Secondary outcome measures

lidocaine levels

vital signs

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: LidocaineExperimental Treatment1 Intervention

Patients in this arm will have gauze soaked with lidocaine applied to the peritonsillar pillars.

Group II: SalinePlacebo Group1 Intervention

Application of saline to the glossopharyngeal nerve.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Royal Victoria Hospital, CanadaLead Sponsor

17 Previous Clinical Trials

10,393 Total Patients Enrolled

Media Library

Lidocaine (Local Anesthetic) Clinical Trial Eligibility Overview. Trial Name: NCT01791439 — N/A

Gagging Research Study Groups: Lidocaine, Saline

Gagging Clinical Trial 2023: Lidocaine Highlights & Side Effects. Trial Name: NCT01791439 — N/A

Lidocaine (Local Anesthetic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01791439 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical study currently open to new participants?

"The clinicaltrials.gov platform indicates that this medical study is not actively recruiting patients at the moment, as it was last updated on February 13th 2013. However, there are two other trials currently enrolling participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese

Albert Moore 2013. "Glossopharyngeal Nerve Blockade for Awake Videolaryngoscope Assisted Endotracheal Intubation in the Morbidly Obese". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01791439.

All > Lidocaine